BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26340408)

  • 1. Novel Insertion Mutation in KCNJ5 Channel Produces Constitutive Aldosterone Release From H295R Cells.
    Hardege I; Xu S; Gordon RD; Thompson AJ; Figg N; Stowasser M; Murrell-Lagnado R; O'Shaughnessy KM
    Mol Endocrinol; 2015 Oct; 29(10):1522-30. PubMed ID: 26340408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
    Murthy M; Xu S; Massimo G; Wolley M; Gordon RD; Stowasser M; O'Shaughnessy KM
    Hypertension; 2014 Apr; 63(4):783-9. PubMed ID: 24420545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma.
    Murthy M; Azizan EA; Brown MJ; O'Shaughnessy KM
    J Hypertens; 2012 Sep; 30(9):1827-33. PubMed ID: 22743686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
    Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.
    Chueh JS; Peng KY; Wu VC; Wang SM; Chan CK; Chen YM; Ke YY; Pan CY; Liao HW
    J Mol Endocrinol; 2021 Sep; 67(4):203-215. PubMed ID: 34463641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
    Williams TA; Monticone S; Crudo V; Warth R; Veglio F; Mulatero P
    Hypertension; 2012 Apr; 59(4):833-9. PubMed ID: 22331379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
    Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
    PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5).
    Shalomov B; Handklo-Jamal R; Reddy HP; Theodor N; Bera AK; Dascal N
    J Physiol; 2022 Mar; 600(6):1419-1437. PubMed ID: 34957562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
    Oki K; Plonczynski MW; Luis Lam M; Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 2012 Apr; 153(4):1774-82. PubMed ID: 22315453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
    Yamada M; Nakajima Y; Taguchi R; Okamura T; Ishii S; Tomaru T; Ozawa A; Shibusawa N; Yoshino S; Toki A; Ishida E; Hashimoto K; Satoh T; Mori M
    Endocr J; 2012; 59(8):735-41. PubMed ID: 22863749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
    Sertedaki A; Markou A; Vlachakis D; Kossida S; Campanac E; Hoffman DA; Sierra ML; Xekouki P; Stratakis CA; Kaltsas G; Piaditis GP; Chrousos GP; Charmandari E
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):845-851. PubMed ID: 27293068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
    Scholl UI; Nelson-Williams C; Yue P; Grekin R; Wyatt RJ; Dillon MJ; Couch R; Hammer LK; Harley FL; Farhi A; Wang WH; Lifton RP
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2533-8. PubMed ID: 22308486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.
    Yang Y; Gomez-Sanchez CE; Jaquin D; Aristizabal Prada ET; Meyer LS; Knösel T; Schneider H; Beuschlein F; Reincke M; Williams TA
    Hypertension; 2019 Oct; 74(4):809-816. PubMed ID: 31446799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
    Tauber P; Penton D; Stindl J; Humberg E; Tegtmeier I; Sterner C; Beuschlein F; Reincke M; Barhanin J; Bandulik S; Warth R
    Endocrinology; 2014 Apr; 155(4):1353-62. PubMed ID: 24506072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
    Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
    J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.